21st American Pharma and Biotech Project, Program and Portfolio Management Conference

2-day CONFERENCE

International in-person conference filled with leading industry speakers.

key information

OUR STORY TO TELL THE WORLD

OUR CONFERENCE PROGRAM

This is not just another PPM conference. This is a conference which tells you a STORY. One story, followed by another, stories of exceptional people who happen to choose Project and Portfolio Management as their way to bring needed medicines to improve the health of millions of people on our planet. Our conference will feature numerous assisted networking sessions which will help you create those critical business friendships needed for fruitful cooperation with professionals from the industry for many years to come. We believe, that our thoughtfully planned conference will fill in any missing pieces in your
plans on the mission to deliver your projects faster, more efficiently and with ease and satisfaction.

Main Takeaways

Testimonials

5/5
Unlike some other similar events, I found relevance in every session within your conference. The content was neither too simplistic nor too advanced. The participants and presenters provided a diverse view of the issues that are present for most in this industry.
Christine Clearwater
Healthcare Manager
5/5
It's a nice place to to meet people, to learn from people, from organization where they start with. In the PMO organization, it's also a nice place where you can hear about a lot about presentations, problems of things they are doing in other organizations, so you can learn of it.
Ronald Aalders
5/5
You know there are a lots of other places that you can go to do talk about project management and portfolio management which I really love, you know a large global meetings like DIA, NF BIO, but there’s nothing like the intimacy that Why summits provides to us and being able to network with the small group of people.
Ailsa Mendez
Executive Director Biotech Portfolio Lead, PPD
5/5
It's a fabulous discussion all around. People are really enthusiastic about sharing their project management insights and collaborating with others.
Derek Shannon
Director Statistical Project Management, Madrigal Pharmaceuticals

Event Speakers

Phil Wolf

SVP, Products and Sales
PDWare

Rahim Merchant

Senior Director, Program Management
Beam Therapeutics

Sathiya Prabaharan

Senior Director, Strategic Initiatives
Integra Lifesciences

Eric Towler

Executive Director, R&D Project Lead
Former Corbus Pharmaceuticals

Ailsa Mendez

Vice President, Business Development
M3 Wake Research

Danielle Metzger

Quality Consultant
Network Partners Group

Danielle Cloutier

Associate Director, R&D Pipeline Decision Analytics
Biogen

Rose Cook

Executive Advisor
Network Partners Group

Christian Lease

Director R&D Project Management Office
Takeda

Darshan Shah

Executive Director, Strategy, Portfolio & Program Management
Incyte

Monika Sharma

Vice President,Product Development
Diagonal Therapeutics

Kris Sprague

Director, Program and Project Planning
Regeneron

Tanaz Farivar

Senior Project Manager
Biogen

Mark Kleinman

Senior Project Director
CSL Behring

Nataraj Dasgupta

Vice President of Analytics
RxDataScience

Karen Gunsior

Senior Director, Project Management
Astra Zeneca

Richard Bayney

President & Founder
Project & Portfolio Value Creation

Michael Faia

Head of R&D, Portfolio Management
Harmony Biosciences

Kundini Amin

Global R&D Business Strategy Leader
Biogen

Hiren Shah

Senior Director, Corporate Technology & Data Global Portfolio Leader
Kenvue

Naima Lockhart Gibson

Senior Director, Product Marketing
Ontada

Stephen Smith

Senior Program Director, Oncology
Corcept Therapeutics

Usha Kidambi

Senior Director, Global Project Management and Leadership
Daiichi Sankyo

Jacob Cancelliere

VP, Account Enablement
Rego Consulting

Chris Bonifield

Sr. Director of Labeling Solutions
Network Partners Group

Richard Sonnenblick

Chief Data Scientist
Planview

Jamie Patterson

Managing Partner
CMK Select

Kirk Dackow

PMP, Vice President, Consulting Delivery and Operations
CMK Select

Kate Pestrichelli

VP Project Management
Network Partners Group

Matthew Azzara

Head, Global Portfolio Management, Oncology
Merck
View More Speakers
HELD AT THE SAME VENUE

Decision Analysis & Portfolio Management Philadelphia

Learn how to frame decision problems and apply Decision Analysis to solve them on the basis of maximization of eNPV.

AGENDA

VIEW ALL SESSIONS & THEIR DESCRIPTIONS

REGISTRATION

Conference

Ticket | April 18-19, 2024
$ 2349
  • Access to All Conference Sessions of the 21th American Pharma and Biotech Project, Program and Portfolio Management Conference
  • Access to Post Conferences Networking
  • Conference Materials
  • Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch

Masterclass

Ticket | April 16-17, 2024
$ 2399
  • Access to Decision Analysis & Portfolio Management Masterclass with Industry Veteran Dr. Richard Bayney.
  • Individual consultancy with the trainer
  • Colored hardcopy of training materials in a binder
  • Electronic copy of trainer's textbook
  • Certificate of completion issued by the trainer

Masterclass + Conference

Ticket | April 16-19, 2024
$ 3749
  • Grants all Masterclass and Conference Ticket Benefits including access to the Decision Analysis & Portfolio Management Masterclass + 21th American Pharma and Biotech Project, Program and Portfolio Management Conference at a special rate.

BECOME A PARTNER

OF this EVENT
  • Present on the Main Stage
  • Hold an exhibit at this event
  • Showcase your Brand in Marketing Material
  • Gain exposure through alternative partnership benefits

event partners

GOLD PARTNER

CMK Select is a Program and Project Management consulting firm focused exclusively within life sciences. Our expert team consists of agency, industry and consulting professionals that can fully manage your key projects end-to-end. Our Project Management Consultants can support Strategic and Tactical Planning, PMO Advisory and Training, Medical and Commercial Launch Management, as well as Pipeline and Commercial Marketing.

GOLD PARTNER

Network Partners is a professional services company delivering tangible results by providing life sciences leaders with the right combination of strategy and professional implementation to move their programs forward.  We support life science companies in the areas of Regulatory Affairs, Quality, Packaging Engineering, Labeling and Project Management. Our team of professionals are led by industry recognized subject matter experts and supported by The Knowledge Bench™.  This collection of information and collaboration keeps our growth mindset team on the cutting edge of industry knowledge and professional development.  

GOLD PARTNER

PDWare(tm) is a provider of dynamic resource and work planning solutions for strategy and portfolio execution. ResourceFirst, our flagship product, emphasizes prioritization, feasibility and execution as the pillars of successful project and program delivery. ResourceFirst™ is available for cloud and on-premise installations, providing first-line managers, executives, PMO and EPPMO functions the agility to meet fluctuating work priorities, schedules, demand and staff capacity. PDWare customers include Medtronic, BD, Synaptics, Teradyne, Motorola, Rockwell, Upsher-Smith and Tektronix.

GOLD PARTNER

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.

GOLD PARTNER

As a Rego Consulting we are premier Project and Portfolio Management (PPM), Work Management, and Agile solutions, services, and training provider, 60% of Fortune 100 companies and 70% of Fortune 20 companies trust Rego Consulting to maximize the return on their investment. Our services cost 20% to 40% less than competitors and our Rego expert guides are all veteran practitioners. Performing Clarity, Rally Software, Apptio, and cross-solution Agile implementations, Rego’s expert guides have refined best practices for over a decade and across every industry. Our focus on maximizing value for our clients helps save them time and money by leveraging our full-solution capabilities, pre-built innovations, integrations, and customizable training offerings.

SILVER PARTNER

Planview has one mission: to build the future of connected work, from ideas to impact. Planview helps organizations accelerate the achievement of what matters most, supporting our customers from need to speed, from passion to progress, and from overhead to optimization. Our connected platform of solutions underpins the business and digital transformations of more than 4,500 customers globally, including 59 of the Fortune 100. Planview empowers enterprises to improve time-to-market and predictability, increase efficiency to unlock capacity, and ensure their most strategic initiatives deliver the desired business outcomes.

STRATEGIC PARTNER

Captario is a software company catering to the pharmaceutical industry. Captario develops SUM® – Strategic Uncertainty Management, a cloud-based modeling & simulation software further empowered by AI and Machine Learning. It enables project and portfolio teams to base strategic decisions on a rich understanding of practically all possible futures. A team can compare options and gain new insights regarding trade-offs between time, cost, risk and value. The approach has consistently led drug project and portfolio teams to substantially increase the overall value. Captario SUM sets a new gold standard for strategic decision making in drug development. Ultimately, this leads to better and more affordable medicines to patients in need.

STRATEGIC PARTNER

Founded in 2017, Intelligencia AI™ is at the forefront of using data science and artificial intelligence (AI) to address significant challenges in the pharmaceutical industry: extremely long drug development timelines, sky-high costs, and unsustainable ROI. Its suite of AI-powered solutions is built on expertly curated scientific and clinical data. The solutions provide actionable insights that help de-risk drug development by providing an accurate, unbiased assessment of a drug’s probability of success at critical points in the drug development process.

Intelligencia AI is headquartered in New York, NY, with offices in San Francisco, CA, and Athens, Greece, and employs 110 individuals globally. Visit intelligencia.ai to discover more. 

AGENDA DOWNLOAD

HELD AT THE SAME VENUE

Decision Analysis & Portfolio Management Philadelphia

Learn how to frame decision problems and apply Decision Analysis to solve them on the basis of maximization of eNPV.